Akero Therapeutics's market cap is currently $3.72B. The company's EPS TTM is $-0.86; its P/E ratio is ―; Akero Therapeutics is scheduled to report earnings on August 8, 2025, and the estimated EPS forecast is $-0.93. See an overview of income statement, balance sheet, and cash flow financials.
